Investor Presentaiton

"Type 1 Use Regulations" and "Biological Diversity Risk Assessment Report" I. Information concerning a recipient organism or the taxonomical species to which the recipient organism belongs 1. Taxonomical position and State of distribution in natural environment 2. History and present state of Use (including history of use for human or animal drugs, or history and present state of industrial use) 3. Physiological and ecological properties (1) Basic properties (2) Environmental conditions allowing colonization or growth (3) Predacity or parasitism (4) Mode of propagation or reproduction (5) Pathogenicity (6) Productivity of harmful substances (7) Other information (including conditions of inactivation)

View entire presentation